Articles by David Nicholson

discusses how he sees the future of electronic biomedical publishing.

has asked contributors to declare potential conflicts of interest, including disclosure of sources of funding.

People who survived the Black Death could have passed on a mutation that prevents the human immunodeficiency virus entering cells.

Editor from his post at Nottingham University inprotest at tobacco industry funding has ignited a fierce debate over ethicsand impartiality in medical research.

The medical community has become split over what to do with its overseeing body, the GMC. Can it reform itself, or will Government have to step in?

The British parliament is to vote on Tuesday 19 December on whether to allow research into stem cell technology to be extended beyond its current boundaries.

Advances in transgenics and drug production are foreseen using chicken eggs, says the Roslin Institute. But why chickens?

Various high-profile genetic projects around the world are pushing the barriers of research. But are they trespassing on human rights?

The UK's National Institute for Clinical Excellence has opted to remove confidentiality from its appraisal process as a means of pre-empting information leaks.

A special report just published in the UK reveals the extent and pace of the gene patent rush.

GM food has provoked much protest but GM medicine has more public approval: the difference lies in approaches to research.

Reed Elsevier's proposed takeover of Harcourt has provoked an outcry from librarians and academics alike - but do they have the muscle to influence it?

The results of the UK government's BSE Inquiry were published on Thursday 26 October, implicating civil servants and scientists in the health scandal.